Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis

INTRODUCTION: Insulin resistance (IR), a risk factor for the development of cardiovascular disease, is common among patients with rheumatoid arthritis (RA). Inflammation, and especially tumour necrosis factor alpha (TNFα), has been associated with IR, and the administration of anti-TNFα agents is su...

Descripción completa

Detalles Bibliográficos
Autores principales: Stavropoulos-Kalinoglou, Antonios, Metsios, Giorgos S, Panoulas, Vasileios F, Nightingale, Peter, Koutedakis, Yiannis, Kitas, George D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580552/
https://www.ncbi.nlm.nih.gov/pubmed/22765047
http://dx.doi.org/10.1186/ar3900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580552/
https://www.ncbi.nlm.nih.gov/pubmed/22765047
http://dx.doi.org/10.1186/ar3900

Ejemplares similares